Comprehensive Introduction to Single Cell Gene Expression Profiling
News Nov 26, 2009
Fluidigm Corporation has developed a new web microsite that provides a comprehensive introduction to the rapidly expanding field of single cell gene expression profiling.
Historically, gene expression profiling of single cells, such as stem cells, circulating tumor and FFPE has been difficult and expensive to perform. Now, however, results from single-cell samples can be obtained using the Fluidigm's BioMark™ System and the company's Dynamic Array™ integrated fluidic circuits (IFCs). Dynamic Array IFCs are ideally suited for high-throughput cell-line studies to determine individual cell behavior in a homozygous population.
Visitors to can gain an understanding of the technology find out how international scientists using Fluidigm Dynamic Array chips are accelerating their research and evaluate whether IFC technology is right for their project.
A five minute audiovisual presentation provides an informative introduction to how IFC technology is now providing a practical means of studying single cells A wide selection of downloadable customer conference posters, peer reviewed publications, success stories and application notes describe the technology in action and the benefits it is delivering to leading laboratories around the world.
Fluidigm develops, manufactures and markets proprietary Integrated Fluidic Circuit (IFC) systems that improve productivity in life science research. Fluidigm's IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in extremely minute volumes. These "integrated circuits for biology" are made possible by miniaturizing and integrating liquid handling components on a single microfabricated microfluidic device.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.